Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

Researchers at Carnegie Mellon University (CMU), in Pittsburgh, are using fluorescent nanoparticles to image tumor tissue during biopsies and surgeries. The imaging technique, which is being tested in rodents, could be particularly useful for precisely spotting tumors during surgeries to remove glioblastomas, one of the most common and aggressive forms of brain cancer. On average, patients survive less than a year after their diagnosis with this deadly form of brain cancer, in part because of the difficulty of surgically removing the entire tumor.

Led by CMU chemist Marcel Bruchez and Steven Toms, director of neurosurgery at the Geisinger Clinic, in Danville, PA, the researchers took crisp fluorescent images of brain tumors, called gliomas, in rats. The rats had been injected with nanoparticles that emit infrared light when they are excited by visible light. The infrared rays made by the nanoparticles can be picked up by a small camera and viewed by surgeons. These quantum dots have a core made of cadmium and telluride, surrounded by a zinc-sulfide shell, which is in turn surrounded by a protective polymer coating.

“This particular type of tumor is poorly distinguishable,” says Bruchez. And when removing brain tumors, surgeons can’t cut wide margins, or patients might lose brain function.

Surgeons removing a brain tumor now rely on a recently taken picture from magnetic resonance imaging (MRI) to orient themselves. But, says Bruchez, “the consistency of the brain is like a bowl of Jell-O. Once you start cutting and removing tissue, things move around, and you can’t rely on presurgery imaging.” He says that surgeons leave behind glioma tissue more than half the time.

One solution to the problem is to run several MRI scans on the patient during the surgery. With this extra guidance, one study showed, surgeons can remove about 15 percent more glioma tissue. But operating rooms that incorporate MRI are expensive, and surgeons must use special tools that won’t be affected by the MRI magnet.

Bruchez and Toms found that glowing quantum dots injected into a rat’s bloodstream are brought to glioma tissue–but not to other areas of the brain–by immune cells called macrophages. These cells engulf debris like nanoparticles and swarm to infected and cancerous tissues as part of the body’s inflammatory response. The macrophages do not go to healthy brain tissue.

0 comments about this story. Start the discussion »

Credit: Marcel Bruchez, CMU

Tagged: Biomedicine, nanotechnology, imaging, nanoparticles, MRI, tumor, medical imaging, infared

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me